BECTON DICKINSON & CO · Surgical & Medical Instruments & Apparatus

BDX

Low riskNext report: Due any day

View price ↗

The short version

A profitable company with steady sales.

Going well

Profitable every year for 10 years
Raised its dividend (2.1% yield)

Money moves

Insiders sold $29K in the last 30 days, all through pre-planned sales
Institutions added 5.8% to their holdings in the quarter ending June 2026 (656 bought, 691 sold)
Held by Ray Dalio (Bridgewater)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$196.39-1.2% that day

Company value: $53.5B; Share price times all shares
Price vs profit (P/E): 59.2x; You pay about $59 for each $1 of yearly profit
Price vs sales: 2.3x; Company value is 2.3 times a year of sales
Dividend yield: 2.1%; Yearly dividend as a share of today's price
Cash vs value: 1%; Cash as a share of company value
Debt vs value: 32%; Debt as a share of company value

From BDX's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$5.0B+5.4% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $23.3B, up 17% from the 12 months before. Over 5 years, sales grew about 6.3% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of BDX. Starting points are the company's recent numbers.

Sales growth+17% a yearRecently: +17% a yearProfit margin4%Last 12 months: 4.0%P/E at the end40xToday: 59.2x. Many steady companies trade at 12x to 25xShare count change0% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$51.0B

Profit in 5 years$2.0B

Price these guesses point to$299.42+52% vs $196.39 todayAbout +8.8% a year, before dividends

What today's price needs: with a 4% margin and a 40x P/E, sales would have to grow about 7.5% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

2/5Weak

MissReturn on equity 15%+Earns a lot on the money owners have in the business.6.6%
MissDebt under half of equityNot relying on borrowed money.0.67x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.7.7%
PassProfitable every yearSteady profits, not one good year.10 of 10 years
PassShare count not growingNot diluting owners. Falling means buybacks.+0.4% in 3 years

Revenue: $21.8B; +8.2% vs prior year
5-year growth: +6.3%/yr; revenue, per year
Total debt: $16.9B; 0.67x equity
Current ratio: 1.05x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: free cash flow positive, gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 6

Revenue: $5.0B; +5.4% YoY
EPS: $1.37; vs $2.00
Op. margin: 13.3%; -2.3 pts
Gross margin: 46.5%; -0.8 pts
Free cash flow: $633.0M
Share count: -4.2%; vs a year ago

Insider rating

Last 90 days

49Mixed

Pre-planned sales of $29K (weaker signal)

50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.

Weekly insider trend

13 weeks agoBoughtSoldThis week

Filing buzz

Last 7 days vs normal

39/ 100

This week: 1
Normal week: 1.7
vs normal: 0.6x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady+5.8%

Institutions added 5.8% to their holdings. 656 bought, 691 sold.

Shares held by institutions277.9M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

-2.1%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

0.6x · $13.5B debt

Shares outstandingLatest reported

272M

Earnings reports

Last 12

Next reportDue any dayEstimated from the same quarter last year

Results filedAug 6
Results filedMay 7
Results filedApr 2
Results filedFeb 9
Results filedNov 6, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

New 5%+ holder (passive)Aug 7 · View filing ↗Big holder New 5%+ holder (passive)Aug 6 · View filing ↗Big holder

Insider trades

Open-market buys and sells, last 90 days

Bought$00 insiders

Sold$29K1 insider, 2 pre-planned

Insider	Trade	Shares	Avg price	Value	Owns after	Date
Michael FeldEVP, Chief Revenue Officer	Sell	76	$198.13	$15K	20K	Oct 26Filing ↗
-0.4% of their holdings Pre-planned sale (10b5-1) Filed 1 day after
Michael FeldEVP, Chief Revenue Officer	Sell	76	$183.70	$14K	20K	Sep 28Filing ↗
-0.4% of their holdings Pre-planned sale (10b5-1) Filed 1 day after